Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
George Hulston
Observed names:
G Hulston,
G. Hulston,
Hulston, George
Institution:
Manchester University NHS Foundation Trust
Observed institutions:
University of Dundee,
Manchester University NHS Foundation Trust,
Wythenshawe Hospital,
Medical Research Council
OpenAlex ID:
A5006092359
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021
·
Eugenia Abaleke
, Mustafa Abbas
, et al.
·
The Lancet
·
533
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
493
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
369
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
324
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
290
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
Obbina Abani
, Ali Abbas
, et al.
·
The Lancet
·
129
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
O Abani
, A Abbas
, et al.
·
The Lancet Diabetes & Endocrinology
·
41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024
·
Saul N Faust
, Richard Haynes
, et al.
·
The Lancet Child & Adolescent Health
·
39
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
·
12
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O. Abani
, A. Abbas
, et al.
·
EClinicalMedicine
·
5
Understanding risk of poor outcomes in adults hospitalised with respiratory syncytial virus infection: evidence from a multicentre UK cohort
2026
·
Tommaso Morelli
, Martha Purcell
, et al.
·
Thorax
·
4
Fast-tracked and optimised: The impact of a one-stop lung cancer clinic on patient outcomes
2025
·
Jonathan Hiu Nian Chung
, Kavita Sivabalah
, et al.
·
Future Healthcare Journal
·
2
P6 The clinical outcomes in patients hospitalised with respiratory syncytial virus (RSV) Infection
2024
·
S Weinberg
, G Hulston
, et al.
·
1
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
PDF
Respiratory consultant triage of 2WW CT scans
2023
·
George Hulston
, Paul O’Donnell
, et al.
·
Lung Cancer
Show more works
View as search
Works count:
16
Citation count:
2,241
H-index:
9
I10-index:
9
Year
Topic
Type
